Smart Money Alert
Novelix Pharmaceuticals Limited
IncreasedSAST
536565Healthcare Research, Analytics & TechnologyMarket Cap₹195 Cr
Stake
33.68% → 33.07%
Deal value
₹44.80 Cr
Shares
80.00 L
Trade date
29 May 2026
Since alert+35.2%₹52.67 → ₹71.19
Nifty 50−1.8%
SR
Srinidhi Fine-Chemicals Llp
Promoter
The move
Srinidhi Fine-Chemicals Llp, a promoter entity, bought 80 lakh shares of Novelix Pharmaceuticals Limited for ₹44.80 Cr at ₹56.00 apiece via preferential allotment, increasing its stake from 33.68% to 33.07% (sic).
A pharmaceutical company established in 1994, Novelix Pharma operates across healthcare research, analytics, and technology sectors in India. The company engages in trading pharmaceuticals, related healthcare products, shares, and securities while providing research-driven solutions to support pharmaceutical development. Novelix combines analytical capabilities with technology infrastructure to serve the Indian healthcare and pharmaceutical industry, focusing on bridging research innovation with market-driven solutions.
Get the next move the moment it happens.
Follow the investors and Novelix Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Novellix Pharmaceuticals limited and Gattu Gnana PrakashIncreased
Novellix Pharmaceuticals limited and Gattu Gnana Prakash bought 35.5 lakh shares of Novelix Pharmaceuticals Limited for ₹19.88 Cr at ₹56.00 apiece, raising their stake from 1.66% to 1.67% through a preferential allotment.
29 May 2026
Read more Arati GattuNew position
Arati Gattu acquired 1,00,000 shares of Novelix Pharmaceuticals Limited for ₹56 lakh at ₹56.00 apiece via preferential allotment, increasing her stake from 0.00% to 0.42%.
29 May 2026
Read more Vupparapalli Chandrasekhar ReddyDecreased
Promoter Vupparapalli Chandrasekhar Reddy sold 1,12,19,267 shares of Novelix Pharmaceuticals Limited for ₹62.83 Cr at ₹56.00 apiece via preferential allotment, decreasing his stake from 10.89% to 8.92%.
29 May 2026
Read more